7月30日，正业生物(ZYBT)盘中上涨3.18%，截至22:59，报5.675美元/股，成交7559.0美元，总市值2.69 亿美元。 本文源自：金融界 作者：行情君 资料显示，正业生物控股有限公司是一家在开曼群岛注册成立的境外控股母公司,主要通过其境内实体 子公司吉林正业生物制品股份有限公司运营。其子公司主要专注于兽医疫苗的研究、开发、制造和销 售,重点是中华人民共和国的牲畜疫苗。 财务数据显示，截至2024年12月31日，正业生物收入总额1.86亿人民币，同比减少11.95%；归母净利润 1131.1万人民币，同比减少64.04%。 ...

Core Viewpoint - Zhengye Biotechnology Holding Limited has received a Delinquency Letter from NASDAQ due to non-compliance with listing requirements, specifically for failing to file its annual report on Form 20-F for the fiscal year ended December 31, 2024 [1][2]. Group 1: Compliance and Regulatory Actions - The Company has 60 calendar days from the date of the Delinquency Letter to submit a Compliance Plan to regain compliance with NASDAQ Listing Rules [2]. - If the Compliance Plan is accepted, NASDAQ may grant an extension of up to 180 calendar days from the filing due date, potentially until November 11, 2025, for the Company to regain compliance [2]. - The Delinquency Letter does not have an immediate impact on the listing of the Company's ordinary shares on the Nasdaq Capital Market [3]. Group 2: Company Overview - Zhengye Biotechnology Holding Limited focuses on the research, development, manufacturing, and sales of veterinary vaccines, particularly for livestock in China [4]. - The operating entity has developed 44 veterinary vaccines for various animals, including swine, cattle, goats, sheep, poultry, and dogs, and its products are available in 28 provincial regions across China and exported to countries like Vietnam, Pakistan, and Egypt [4]. - The Company operates three GMP veterinary vaccine production floors with 13 GMP vaccine production lines and employs 49 individuals with over a decade of experience in the veterinary vaccine industry [4].

Market Overview - US stock indices experienced a significant rise for the third consecutive trading day, with the Dow Jones up 486.83 points (1.23%), Nasdaq up 457.99 points (2.74%), and S&P 500 up 108.91 points (2.03%) on April 24 [1] Technology Sector Performance - Major tech stocks saw substantial gains, with Tesla, Amazon, and Microsoft rising over 3%, while Google and Meta increased by more than 2%, and Apple rose nearly 2% [2] - The semiconductor sector led the gains, with Micron Technology and Broadcom up over 6%, Intel and AMD rising over 4%, and Nvidia increasing by more than 3% [2] - Nvidia's market capitalization increased by $90.8 billion (approximately ¥661.8 billion) in one night [2] Company Earnings Reports - Alphabet (Google's parent company) reported Q1 revenue of $90.23 billion, a 12% year-over-year increase, exceeding the expected $89.1 billion. Earnings per share were $2.81, up from $1.89 a year ago, and also above the forecast of $2.01. The operating profit was $30.61 billion, a 20% increase year-over-year, surpassing the expected $28.86 billion. The board authorized a stock buyback of up to $70 billion [6] - Intel reported Q1 revenue of $12.67 billion, a slight decline of 0.4% year-over-year, but above the expected $12.31 billion. Adjusted earnings per share were $0.13, down from $0.18 a year ago, but above the forecast of $0.01. The data center and AI revenue was $4.13 billion, exceeding the analyst expectation of $2.96 billion. Intel projected Q2 revenue between $11.2 billion and $12.4 billion, below the market estimate of $12.88 billion. The company reduced its total capital expenditure target for 2025 from $20 billion to $18 billion, leading to a post-earnings drop of over 7% in its stock [7] Chinese Stocks Performance - The Nasdaq Golden Dragon China Index rose by 0.68%, with notable gains in popular Chinese stocks such as NIO and Futu Holdings, which increased by over 6%, and Pinduoduo, Baidu, NetEase, and Bilibili rising over 2%. Xpeng Motors surged by 39.41%, and ZYBT rose by 34.91% [7][8] Commodity Market - International precious metals futures saw a general increase, with COMEX gold futures rising by 2.04% to $3,361.30 per ounce, and WTI crude oil futures up by 0.84% to $62.79 per barrel [9]